chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Feb2021 as dose 1, single (Lot number: EN6203), in right arm, on 20Mar2021 as dose 2, single (Lot number: ER2613), in right arm and on 13Nov2021 as dose 3 (booster), single (Lot number: 320308D) at the age of 49 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Allergies" (unspecified if ongoing); "chronic bronchitis" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Paxlovid rebound; (12Jul2022) Positive, notes: Return of symptoms and positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Patient received no other medication in 2 weeks.  No follow-up attempts are needed. No further information is expected.
This is a spontaneous report from a contactable consumer (patient). A 50-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0150), at the age of 50, via an unspecified route of administration, left arm, on Apr 6, 2021, at 16:15, single dose, for COVID-19 immunisation. Medical history reported as none. Concomitant medications included Lo Loestrin Fe (ethinyl-estradiol, ferrous fumarate, norethisterone acetate), started on unknown date; for unknown indication. The patient has no known allergies. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6208), at the age of 50, via an unspecified route of administration, left arm, on Mar 11, 2021, at 16:15, single dose, for COVID-19 immunisation. Prior to the vaccination, patient not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 7, 2021 at 12:00, patient experienced nausea, vomited once, exhaustion and headache. Therapeutic measures were not taken as a result of these events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event vomited once recovered on Apr 7, 2021; while that of nausea, exhaustion and headache recovered on an unknown date in Apr 2021. No follow-up attempts needed. No further information expected.
Nurse inadvertantly sprayed part of 2nd half dose of Monovalent Flu Mist onto the paitent's right side of face. Nurse told patient to immediately wash face.  Patient complied.  Patient returned to work and changed his shirt.  He also took out disposable contact lens, rinsed and replaced it.  His eye then became teary.  Patient reported it to his supervsior and then called us (the health department.)  This morning about 10 AM, patient reports to having no problems.  He reports conjuctiva is not reddened or weepy. Patient was told to contact his eye doctor or his regular physician if he had any further problems.
adult patient received an unspecified number of doses of PROQUAD; This spontaneous report was received from an unspecified healthcare provider and refers to an unspecified adult patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with an unspecified number of doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (formulation, strength, therapy type, dose, frequency, route and site of administration, lot # and expiration date were not reported) for prophylaxis.
Left arm is very painful and red, swollen, barely can lift arm. Warm to touch on shoulder area with hives.
patient received her first dose in 2028 but missed her second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Mom reports incidence where she found pt to be pale. No responsiveness, lethargy, without associated fever or feeding.
the patient broke out into mumps with swelling on the face; This spontaneous report concerns a 4 year old female patient, was received via medical records. Information about the patient's medical history, concurrent conditions, concomitant medications and drug reactions or allergies was not provided.      On 23-FEB-2016, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (rHA) (lot # L026551), subcutaneously on the left side, for prophylaxis (strength, dose and frequency were not provided). On the same date, the patient was vaccinated with the second dose of influenza virus vaccine (unspecified)(manufacturer unknown) intramuscular route of administration in the left thigh, for prophylaxis (Lot # 45387db with an expiration date in 30-SEP-2019) (strength, dose and frequency were not provided).      On 30-APR-2019, the patient broke out into mumps with swelling on the face (mumps). As a result, the patient was advised to go to the emergency room if the swelling progressed, and on 01-MAY-2019, the patient was taken to the hospital to the physician's office, where a blood test confirmed the development of mumps disease and subsequently on the same date, some additional laboratories were also performed as follows: Mumps abs, IgG-LC 244.0 (range and units not provided) and Mumps Antibodies, IgM-LC 1.37 (H) (range and units not provided). However, it was unknown if any treatment was given to the patient for the experienced event.         At the time of reporting, the outcome of mumps was reported as resolving.   The causal relationship between measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), influenza virus vaccine (unspecified)(manufacturer unknown) and the reported mumps was not provided.        All available medical records will be provided upon request
Information has been received from a physician concerning a female who was vaccinated with Gardasil.  The physician reported that 3 weeks after receiving her 3rd dose of Gardasil, the patient developed a little fatty tumor on her shoulder that the physician described as a benign lipoma.  The patient went to a dermatologist.  Additional information has been requested. 07/08/08 Initial and follow-up information has been received from a physician concerning a 20 year old female, with a history of allergic reaction to SEPTRA, who on 12-DEC-2007 was vaccinated intramuscularly in the left deltoid with her third dose of GARDASIL (lot # 659437/1266U). The physician reported that 3 weeks after receiving her 3rd dose of GARDASIL (also reported a 15-Dec-2007), the patient developed a little fatty tumor on her shoulder that the physician described as a benign lipoma (also described as a cystic lesion). The patient went to a dermatologist. The benign lipoma spontaneously went away two months later, and the patient has recovered. Additional information has been requested.
I received the COVID 19 vaccine at approximately 5pm May 1, 2021. At approximately 1 am, May 2nd, I  woke up shaking uncontrollably. I had a fever at the time. The shaking happened in episodes, and these episodes lasted 5-10 minutes, about a minute or 2 apart for about 30 minutes. I was still able to get up once during the shaking, and I was fully conscious. The shaking made my heart race, and I was very sore and had a hard time sleeping after the shaking finished.
No adverse reaction noted. Patient is a 3 yo given FLULAVAL flu vaccine which is indicated for greater than or equal to 18 yo.
Several minutes after receiving vaccine, patient became unconscious and appeared to have seizure like symptoms. After 1 or 2 minutes, patient retained consciousness and felt ok. Paramedics were called but his mother picked him up to take to emergency room.
come down with the flu; shivers; muscle pain; fatigue; headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) as dose ,2 single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt2162b2, for Covid-19 immunization, reaction(s): "Minor fatigue". The following information was reported: INFLUENZA (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "come down with the flu"; CHILLS (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "shivers"; MYALGIA (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "muscle pain"; FATIGUE (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "fatigue"; HEADACHE (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "headache". Therapeutic measures were not taken as a result of influenza, chills, myalgia, fatigue, headache.as "headache".    Additional information: Patient is non pregnant. vaccine location-Left arm, dose number-2. if other vaccine in four weeks -Unknown. other medications in two weeks -unknown. Adverse Event start-  This was a person cutting my hair who mentioned that after shot 1 she felt minor fatigue and that's it - but after shot 2 she felt like she had come down with the flu, complete with shivers, muscle pain, fatigue, and headache for a full 24 hours afterwards. This mention occurred 2 hours ago. if treatment ae- No. If covid prior vaccination- Unknown.if covid tested post vaccination- unknown. known allergies -unknown. other medical history-unknown  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After the shot, sick, tired, aches and pains for two - three days.   Day 3 - 5 Dizziness, blurred vision.  Day 5 went to the hospital, ER found sign of stroke.  Day 7 saw a neurologist, was told that a stroke occurred, but was not sure if it was new or old.  Day  12, massive Ischemic Stroke followed by multiple hemorrhages.  The Clot left a 10mm hole in the left side of the brain.
Vaccination given 11/05/09 around 3:00 pm. No reaction until 11/06/09 around 7:00 pm, when I developed fever, aching. and muscle pain which lasted for 3 days. Felt weak for 3 more days.
Intussusception 5/5/08. Treated with air enema with full recovery. 5/22/2008 MR received for DOS 5/6-7/2008 with D/C DX:  S/P reduction of Intussusception by Barium Enema.  Infant presented to ER with 2 day hx of bloody stool and irritability.  Barium Enema (+) for ileocolic IS which was fully reduced on 2nd attempt. D/C next day tolerating feeds and in no distress.
Painful swelling in armpit lymph node two days after immunization.   Also had the expected flu-like side effects the days prior, starting about 6 hours after immunization, peaking in a fever at about hour 18, and mostly subsiding about 36 hours after immunization.
Information has been received from a medical assistant concerning a 6-year-old female who on 18-NOV-2003 was vaccinated in the right upper arm with a second dose of Varivax (Lot # 646229/0538N). On 08-MAR-2006 the patient broke out with about 20-30 pox total. Subsequently, the patient recovered. Additional information has been requested.
Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-035051 (E2B Linked Report).; Sender's Comments:  MOD-2021-035051:Crosslinked case
One hour following vaccination: Child was unresponsive; slept for longer than 6 hours. Awoke with a fever of 103.0 F and high pitched scream with back arching. Inconsolable crying throughout the night. This pattern continued to repeat itself, every night for 5 nights straight. The following day- the child could no longer crawl, talk or walk. All language was lost and child only reacted with a high pitched squeal. Previous language included 10-20 words, child crawled independently by 6 months and was walking mostly independently at the time of the vaccination. Child was vaccinated on a delayed vaccination schedule due to previous illness requiring hospitalization and time constraints.
mal-administration; headache; muscle aches; limited range of motion; This case was reported by a consumer via call center representative and described the occurrence of headache in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In July 2018, the patient received the 1st dose of Shingrix. In April 2019, the patient received the 2nd dose of Shingrix. In July 2018, 1 day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced headache, muscle pain and injected limb mobility decreased. In April 2019, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the headache, muscle pain and injected limb mobility decreased were recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the headache, muscle pain and injected limb mobility decreased to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix on left arm. In April 2019, the patient received the 2nd dose of Shingrix, which led to lengthening of the vaccination schedule. The patient experienced the side effects 24 hours after her first dose. The effects lasted for 5 days and resolved.  The reporter consented to follow up.
Client developed Bell's Palsy on right side of face approximately 2 weeks after receiving vaccine. Client reports his PCP is treating with steroids, which has helped.
Office visit for Arm Pain: Onset: 2 days ago.  Duration: more than 1 hour. Severity level is moderate.  It occurs constantly and is worsening. Location: left (upper arm). The pain radiates to the  The pain is aching and throbbing. Context: there is no injury.  The pain is aggravated by movement. There are no relieving factors.  Associated symptoms include swelling.  Pertinent negatives include joint tenderness and tingling in the arms. Additional information: pt had two vaccines in upper arm 2 days ago, started having pain, swelling in area and them became red and warm, painful to move arm, has not taken anything for pain. Assessment and Plan:  Cellulitis of the left upper extremity.  Will not give antibiotic shot due to possible cross allergy with PCN (Rx sent to pharm).  Use ice pack or heat on area to help with pain and swelling, if gets worse, redness spreads, start to run a fever please go to the emergency room for treatment. Follow up with us in one week or sooner if needed, if better do not need to follow up. I called patient today (11/7) and he says his L shoulder is still tender to the touch.  He says the redness and swell is down, doesn't feel it.  He is still taking the antibiotic.
Leg and arm weakness; This is a spontaneous report from a contactable nurse, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 07Apr2021 at 10:45 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 08Apr2021, the patient experienced leg and arm weakness. The patient experienced the sensation which continued even after 9 days post vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event leg and arm weakness was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
soreness, muscle aches; also, patient said she has some nerve damage from the flu vaccine administration
Patient came into pharmacy 12-5-17 stating redness, itchy, and heat around injection site. Also, some swelling around the red area.
Hives all over body lasted about 2 days. Reduced with Benadryl and would reappear once dosage wore off.
Pt experienced an episode of loss of consciousness at work and was taken to the ER where she was treated and sent home.  Pt was not hospitalized.  The pts experience was felt to be an important medical event.
This spontaneous report as received from a pharmacist via a company representative refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (route, dose and lot # were unknown). On an unknown date the patient developed shingles 2 weeks after receiving a dose of ZOSTAVAX. The outcome of shingles was unknown. Additional information has been requested.
Infection at vaccine site. Seen by MD & given oral course of antibiotics. One f/u visit required.
COVID-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included VALSARTAN and ATENOLOL for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
The bivalent was given as the first dose.  No symptoms or adverse events, patient tolerated vaccine well.
Patient complained of anxiety and mouth tingling.  Hx of anxiety and panic attacks, takes adderall.  Cleared by EMS. Instructed patient to call his PCP, 911, or go to the nearest emergency room for any further issues.
Body aches for approximately 16 hours, extreme nausea and dizziness briefly leading to a single syncopal episode. Used Tylenol for body aches, no other treatment necessary. Nurse at Obgyn's office advised me to stay hydrated and monitor temperature.  Feeling normal the day after episode. I am 16 weeks pregnant with pregnancy #2, estimated due date is 8/4/21
Information has been received from a health professional concerning a 9 week old female who on 16-SEP-2008 was vaccinated po with the first 2 ml dose of ROTATEQ (lot# 660375/0196X). Concomitant therapy included PREVNAR, PEDIARIX and ACTHIB, all given on the same day (also reported as given 18-SEP-2008) as ROTATEQ. A nurse reported immediately after the vaccines were given (also reported as a half an hour after vaccination) the child vomited several times, several forceful episodes. The child recovered within 30 minutes on the same day and had medical attention in the office. No other information was given. A product quality complaint was not involved. Additional information has been requested. 12/3/08 This is in follow-up to report(s) previously submitted on 10/13/2008. No further information is expected.
Rapid heartbeat; Dizziness; Blood pressure went to 200/104; Trigger thumb; right hand ring finger became trigger; Both palms of hand and fingers became very painful; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Mar2021 at 10:00 as dose 1, single (Lot number: ER8733) at the age of 74 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "Degenerated disk disease" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing); "Allergies to eggs" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL; LISINOPRIL; HYDROCHLOROTHIAZIDE; NAPROX [NAPROXEN]. Past drug history included: Codeine, reaction(s): "Drug allergy"; Demerol, reaction(s): "Drug allergy"; Morphine, reaction(s): "Drug allergy"; Loritab, reaction(s): "Drug allergy". The patient had no other vaccine in four weeks. The following information was reported: BLOOD PRESSURE INCREASED (disability) with onset 05Jul2021 at 08:00, outcome "recovered", described as "Blood pressure went to 200/104"; PAIN IN EXTREMITY (disability) with onset 05Jul2021 at 08:00, outcome "not recovered", described as "Both palms of hand and fingers became very painful"; DIZZINESS (disability) with onset 05Jul2021 at 08:00, outcome "recovered"; HEART RATE INCREASED (disability) with onset 05Jul2021 at 08:00, outcome "recovered", described as "Rapid heartbeat"; TRIGGER FINGER (disability) with onset 05Jul2021 at 08:00, outcome "not recovered", described as "Trigger thumb; right hand ring finger became trigger". The events "rapid heartbeat", "dizziness", "blood pressure went to 200/104", "trigger thumb; right hand ring finger became trigger" and "both palms of hand and fingers became very painful" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: (05Jul2021) 200/104; Heart rate: (05Jul2021) Rapid. Therapeutic measures were taken as a result of trigger finger. Per clinical course, the patient experienced rapid heartbeat, dizziness, and blood pressure went to 200/104 on 05Jul2021. On 05Jul2021, the patient had trigger thumb (R hand), orthopedic injected steroid shot in Sep2021. Following month (Aug2021), left thumb became trigger thumb, another steroid shot. In Dec2021, right hand ring finger became trigger, another steroid shot. Within a month, both palms of hand and fingers became very painful (starting on 05Jul2021) and are getting worse. The patient had seen other doctors including RA physicians on 08Sep2022 with no results. The patient did not suffer any of this until she had the vaccine.